VIATRIS INC. Proceeds from Derivative Instrument, Investing Activities
VIATRIS INC. (VTRS) reported Proceeds from Derivative Instrument, Investing Activities of $3.40 million for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromDerivativeInstrumentInvestingActivities · last filed 2026-08-06
- VIATRIS INC. proceeds from derivative instrument, investing activities for the quarter ending 2025-12-31 was $3.40M.
- VIATRIS INC. proceeds from derivative instrument, investing activities for the quarter ending 2025-09-30 was $3.40M.
| Period end | Proceeds from Derivative Instrument, Investing Activities 3 month | Proceeds from Derivative Instrument, Investing Activities 6 month |
|---|---|---|
| 2025-12-31 | $3.40M 10-Q · filed 2026-08-06 | $6.80M derived: sum of 2 quarters · filed 2026-08-06 |
| 2025-09-30 | $3.40M 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |